Press release
Subcutaneous Immunoglobulin (SCIG) Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities
Subcutaneous Immunoglobulin (SCIG) Market
What Is the Projected Growth of the Subcutaneous Immunoglobulin (SCIG) Market?
The subcutaneous immunoglobulin (SCIG) market has grown rapidly in recent years. It is expected to rise from $12.72 billion in 2024 to $14.52 billion in 2025, reflecting a CAGR of 14.1%. The growth is due to the rising prevalence of immunodeficiency disorders, increased patient preference for home-based treatments, enhanced therapeutic efficacy, higher awareness and diagnosis rates, and favorable reimbursement policies.
The subcutaneous immunoglobulin (SCIG) market is forecasted to grow rapidly to $24.29 billion by 2029 at a CAGR of 13.7%. Growth drivers are rising cases of neurological and autoimmune disorders, growing immunoglobulin therapy awareness, broader application in neurology and dermatology, and expanding healthcare infrastructure. Major trends include advancements in delivery systems, rising preference for home infusions, antibody therapy innovations, and new SCIG formulations.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15935
What Are the Different Subcutaneous Immunoglobulin (SCIG) Market Segments?
The subcutaneous immunoglobulin (SCIG) market covered in this report is segmented -
1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)
2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications
3) By End-Use: Clinics, Hospitals, Homecare, Other End-Uses
Subsegments:
1) By Immunoglobulin A (IgA): IgA1, IgA2
2) By Immunoglobulin G (IgG): IgG1, IgG2, IgG3, IgG4
3) By Immunoglobulin M (IgM): Pentameric IgM, Hexameric IgM
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15935&type=smp
What Are the Primary Drivers Shaping the Subcutaneous Immunoglobulin (SCIG) Market?
The growing prevalence of secondary immunodeficiency diseases is expected to fuel the growth of the subcutaneous immunoglobulin market. Secondary immunodeficiency diseases occur when the immune system is weakened due to factors like aging, immunosuppressive treatments, or environmental toxins. Subcutaneous immunoglobulin therapy provides antibodies that help strengthen the immune system, particularly in chronic conditions like HIV. For example, in the UK, there was a 22% increase in new HIV diagnoses in 2022. This rise in secondary immunodeficiency diseases is contributing to the growth of the subcutaneous immunoglobulin market.
Which Companies Are Leading in the Subcutaneous Immunoglobulin (SCIG) Market?
Major companies operating in the subcutaneous immunoglobulin (SCIG) market are Pfizer Inc., Johnson & Johnson, Prothena Corporation plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Baxter International Inc., CSL Behring, Lonza Group, Grifols S.A., Octapharma AG, Dr. Reddy's Laboratories, Intas pharmaceutical Ltd., Emergent BioSolutions Inc., Kedrion Biopharma, LFB group, Biotest AG, Argenx SE, Bio Products Laboratory Ltd., ADMA Biologics Inc., Sino Biological Inc., Bharat Serums and Vaccines Limited (BSV), Kamada Pharmaceuticals, CinnaGen Co., Shire plc
What Trends Are Driving Growth in The Subcutaneous Immunoglobulin (SCIG) Market?
Major companies in the subcutaneous immunoglobulin market are focusing on developing subcutaneous human-klhw, a special formulation of human immune globulins (Ig) aimed at strengthening the immune system. For example, in March 2022, Grifols S.A., a pharmaceutical company based in Spain, launched XEMBIFY 20% subcutaneous immunoglobulin (SCIG) to treat primary immunodeficiency diseases. XEMBIFY is a ready-to-use formulation that is stable at room temperature for up to 24 months, eliminating the need for refrigeration during storage and transportation.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report
What Are the Top Revenue-Generating Geographies in the Subcutaneous Immunoglobulin (SCIG) Market?
North America was the largest region in the subcutaneous immunoglobulin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (SCIG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Subcutaneous Immunoglobulin (SCIG) Market?
2. What is the CAGR expected in the Subcutaneous Immunoglobulin (SCIG) Market?
3. What Are the Key Innovations Transforming the Subcutaneous Immunoglobulin (SCIG) Industry?
4. Which Region Is Leading the Subcutaneous Immunoglobulin (SCIG) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Subcutaneous Immunoglobulin (SCIG) Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities here
News-ID: 4043616 • Views: …
More Releases from The Business Research Company
Leading Companies Reinforce Their Presence in the Blanket Market
The blanket market is steadily gaining traction as consumers increasingly seek comfort and style in their home essentials. With evolving preferences and technological advancements, this sector is set to experience consistent growth. Let's explore the current market value, key players, emerging trends, and the main segments fueling this expansion.
Forecasted Blanket Market Size and Growth Trajectory
The blanket market has seen consistent growth over recent years. From a market size…
Global Trends Review: The Rapid Evolution of the Sporting and Athletic Goods Mar …
The sporting and athletic goods market is experiencing steady growth, driven by evolving consumer preferences and technological advancements. As health and wellness continue to gain importance globally, this market is set for notable expansion in the coming years. Let's explore the current market size, key factors fueling its growth, leading companies, major trends, and segmentation details.
Forecast for Sporting and Athletic Goods Market Size Through 2029
The sporting and athletic…
Train Seat Market Overview, Key Growth Factors, and Insights on Top Players
The train seat industry is experiencing notable growth, driven by advancements in technology and increasing demand for improved passenger comfort. As rail travel evolves, so does the need for innovative, efficient, and adaptable seating solutions that cater to modern requirements. Let's explore the current market status, key players, trends, and segments shaping the future of train seating.
Train Seat Market Size and Growth Expectations
The train seat market has seen…
Leading Companies Solidifying Their Presence in the Spunbond Nonwovens Market
The spunbond nonwovens industry has been experiencing notable growth and shows promising prospects for the coming years. This expanding market is being driven by several innovations and increasing demand across diverse sectors, signaling a robust future.
Projected Growth and Market Size of the Spunbond Nonwovens Market
The spunbond nonwovens market has demonstrated solid expansion recently, with its size expected to rise from $15.57 billion in 2024 to $16.59 billion in…
More Releases for SCIG
Leading Companies Reinforce Their Presence in the Subcutaneous Immunoglobulin (S …
The subcutaneous immunoglobulin (SCIG) market is poised for significant expansion in the coming years, driven by various healthcare advancements and increasing demand. This report takes a detailed look at the market's value projections, key players, emerging trends, and the main segments propelling growth in this vital medical field.
Market Size Outlook and Growth Drivers for the Subcutaneous Immunoglobulin (SCIG) Market
The SCIG market is expected to experience rapid growth, reaching…
Subcutaneous Immunoglobulin (SCIG) Market: Major Trends Reshaping the Future of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Subcutaneous Immunoglobulin (SCIG) Industry Market Size Be by 2025?
Recent years have seen a swift expansion of the subcutaneous immunoglobulin (SCIG) market. The market, which stood at $12.72 billion in 2024, is projected to rise to $14.52 billion by 2025, reflecting a compound annual growth rate…
Boosting Immunity: Innovations in Subcutaneous Immunoglobulin (SCIG)
The Business Research Company recently released a comprehensive report on the Global Subcutaneous Immunoglobulin (SCIG) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your…
Subcutaneous Immunoglobulin (SCIg) Market - Global Industry Analysis, Size, Shar …
Immunoglobulin, commonly known as an antibody, is a Y-shaped protein manufactured primarily by plasma cells. Immunoglobulin is utilized by the immune system to counterbalance pathogens. Subcutaneous injections are administered as vaccines and medications including insulin and immunoglobulin. The process of administering immunoglobulin is known as immunoglobulin therapy. When immunoglobulin therapy is applied below the dermis and epidermis, or cutis, it is known as subcutaneous immunoglobulin. Subcutaneous therapy is useful as…
Subcutaneous Immunoglobulin (SCIg) Market Size, Status and Forecast 2024
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size.
Immunoglobulin replacement therapy (IRT) is the systematic care for patients with antibody deficit. Immunoglobulin replacement therapy can be of two types: subcutaneous immunoglobulin (SCIg) and intravenous immunoglobulin (IVIg). The choice of treatment depends upon numerous factors such as clinical symptoms, patient physiognomies, intravenous access, and possible side…
Subcutaneous Immunoglobulin (SCIg) Market By Current & Upcoming Trends Analysis …
Immunoglobulin, commonly known as an antibody, is a Y-shaped protein manufactured primarily by plasma cells. Immunoglobulin is utilized by the immune system to counterbalance pathogens. Subcutaneous injections are administered as vaccines and medications including insulin and immunoglobulin. The process of administering immunoglobulin is known as immunoglobulin therapy. When immunoglobulin therapy is applied below the dermis and epidermis, or cutis, it is known as subcutaneous immunoglobulin. Subcutaneous therapy is useful as…
